A soy-yoghurt-honey product as a therapeutic functional food: mode of action and narrative review

por Berg, Aloys, McCarthy, H. David
Publicado 2022

RANK, RANKL and osteoprotegerin in bone biology and disease

por Wright, H. L., McCarthy, H. S., Middleton, J., Marshall, M. J.
Publicado 2009

A Rare Case of an Early Postoperative Obstructive Ileus in a Young Female Patient due to a Residual Trichobezoar Mass

por Christopoulos, P., Ross-Thriepland, S., McCarthy, H., Day, C. S., Sasi, W.
Publicado 2016

Coexistence of cystic fibrosis and phenylketonuria.

por Greeves, L. G., McCarthy, H. L., Redmond, A., Carson, D. J.
Publicado 1997

Injected human umbilical cord-derived mesenchymal stromal cells do not appear to elicit an inflammatory response in a murine model of osteoarthritis

por Perry, J., McCarthy, H.S., Bou-Gharios, G., van 't Hof, R., Milner, P.I., Mennan, C., Roberts, S.
Publicado 2020

P1149: THE EVOLVING STATE OF PLAY IN 1000 PATIENTS WITH WALDENSTRÖM’S MACROGLOBULINAEMIA IN THE UNITED KINGDOM (UK): A REAL-WORLD DATA ANALYSIS FROM THE WMUK RORY MORRISON REGISTRY...

por Uppal, E., Otamas, A., Khwaja, J., McCarthy, H., Kothari, J., Rismani, A., El-Sharkawi, D., Kyriakou, C., D’Sa, S.
Publicado 2022

P1130: ACALABRUTINIB IN TREATMENT-NAIVE OR RELAPSED/REFRACTORY WALDENSTRÖM MACROGLOBULINEMIA: 5-YEAR FOLLOW-UP OF A PHASE 2, SINGLE-ARM STUDY

por Owen, R., McCarthy, H., Rule, S., D’Sa, S., Thomas, S., Tournilhac, O., Forconi, F., José Kersten, M., Luigi Zinzani, P., Iyengar, S., Kothari, J., Minnema, M., Kastritis, E., Cheson, B., Walter, H., Greewald, D., Calvo, R., Wun, C.-C., Furman, R.
Publicado 2022

Longitudinal copy number, whole exome and targeted deep sequencing of 'good risk' IGHV-mutated CLL patients with progressive disease

por Rose-Zerilli, M J J, Gibson, J, Wang, J, Tapper, W, Davis, Z, Parker, H, Larrayoz, M, McCarthy, H, Walewska, R, Forster, J, Gardiner, A, Steele, A J, Chelala, C, Ennis, S, Collins, A, Oakes, C C, Oscier, D G, Strefford, J C
Publicado 2016

P1161: ASPEN: LONG-TERM FOLLOW-UP RESULTS OF A PHASE 3 RANDOMIZED TRIAL OF ZANUBRUTINIB (ZANU) VS IBRUTINIB (IBR) IN PATIENTS (PTS) WITH WALDENSTRÖM MACROGLOBULINEMIA (WM)

por Dimopoulos, M., Opat, S., D’Sa, S., Jurczak, W., Lee, H.-P., Cull, G., Owen, R. G., Marlton, P., Wahlin, B. E., Garcia-Sanz, R., McCarthy, H., Mulligan, S., Tedeschi, A., Castillo, J. J., Czyz, J., Fernandez De Larrea Rodriguez, C., Belada, D., Libby, E., Matous, J., Motta, M., Siddiqi, T., Tani, M., Trneny, M., Minnema, M., Buske, C., Leblond, V., Treon, S. P., Trotman, J., Chan, W. Y., Schneider, J., Allewelt, H., Cohen, A., Huang, J., Tam, C. S.
Publicado 2022